Ризици трансфузије и дилеме

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (отвара нови прозор)

Al-Refaie WB, Parsons HM, Markin A, Abrams J, Habermann EB.

Извор‎: Surgery 2012;152(3):344-54.

Индекс‎: PubMed 22938895

DOI‎: 10.1016/j.surg.2012.06.008

https://www.ncbi.nlm.nih.gov/pubmed/22938895 (отвара нови прозор)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (отвара нови прозор)

Ferraris VA, Davenport DL, Saha SP, Austin PC, Zwischenberger JB.

Извор‎: Arch Surg 2012;147(1):49-55.

Индекс‎: PubMed 22250113

DOI‎: 10.1001/archsurg.2011.790

https://www.ncbi.nlm.nih.gov/pubmed/22250113 (отвара нови прозор)

Adverse blood transfusion outcomes: establishing causation. (отвара нови прозор)

Isbister JP, Shander A, Spahn DR, Erhard J, Farmer SL, Hofmann A.

Извор‎: Transfus Med Rev 2011;25(2):89-101.

Индекс‎: PubMed 21345639

DOI‎: 10.1016/j.tmrv.2010.11.001

https://www.ncbi.nlm.nih.gov/pubmed/21345639 (отвара нови прозор)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (отвара нови прозор)

Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, Starr NJ, Blackstone EH.

Извор‎: Crit Care Med 2006;34(6):1608-16.

Индекс‎: PubMed 16607235

DOI‎: 10.1097/01.CCM.0000217920.48559.D8

https://www.ncbi.nlm.nih.gov/pubmed/16607235 (отвара нови прозор)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (отвара нови прозор)

Marik PE, Corwin HL.

Извор‎: Crit Care Med 2008;36(9):2667-74.

Индекс‎: PubMed 18679112

DOI‎: 10.1097/CCM.0b013e3181844677

https://www.ncbi.nlm.nih.gov/pubmed/18679112 (отвара нови прозор)

Survival rate changes with transfusion of blood products during liver transplantation. (отвара нови прозор)

Massicotte L, Sassine MP, Lenis S, Seal RF, Roy A.

Извор‎: Can J Anaesth 2005;52(2):148-55.

Индекс‎: PubMed 15684254

DOI‎: 10.1007/BF03027720

https://www.ncbi.nlm.nih.gov/pubmed/15684254 (отвара нови прозор)

Emerging infectious disease agents and their potential threat to transfusion safety. (отвара нови прозор)

Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KR, Dodd RY.

Извор‎: Transfusion 2009;49 Suppl 2:1S-29S.

Индекс‎: PubMed 19686562

DOI‎: 10.1111/j.1537-2995.2009.02279.x

https://www.ncbi.nlm.nih.gov/pubmed/19686562 (отвара нови прозор)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (отвара нови прозор)

Stramer SL.

Извор‎: ISBT Sci Ser 2014;9(1):30-6.

Индекс‎: PubMed 25210533

DOI‎: 10.1111/voxs.12070

https://www.ncbi.nlm.nih.gov/pubmed/25210533 (отвара нови прозор)

ПЕРИОПЕРАТИВНА НЕГА

Ризици трансфузије и дилеме

српски (ћирилица)

Ризици трансфузије и дилеме

https://assetsnffrgf-a.akamaihd.net/assets/ct/46e9307b0a/images/syn_placeholder_sqr.png

Blood transfusion and cancer surgery outcomes: a continued reason for concern. (отвара нови прозор)

Surgical outcomes and transfusion of minimal amounts of blood in the operating room. (отвара нови прозор)

Adverse blood transfusion outcomes: establishing causation. (отвара нови прозор)

Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. (отвара нови прозор)

Efficacy of red blood cell transfusion in the critically ill: a systematic review of the literature. (отвара нови прозор)

Survival rate changes with transfusion of blood products during liver transplantation. (отвара нови прозор)

Emerging infectious disease agents and their potential threat to transfusion safety. (отвара нови прозор)

Current perspectives in transfusion-transmitted infectious diseases: emerging and re-emerging infections. (отвара нови прозор)

Контакт с локалним представницима

Медицинске информације

Филмови

Интервју са Пијом ди Бенедето, др мед.

Ризици трансфузије и дилеме

Изабери језик

Подели